Aquavit Revenue and Competitors
Estimated Revenue & Valuation
- Aquavit's estimated annual revenue is currently $23.2M per year.
- Aquavit's estimated revenue per employee is $270,000
Employee Data
- Aquavit has 86 Employees.
- Aquavit grew their employee count by 8% last year.
Aquavit Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.8M | 65 | 33% | N/A | N/A |
#2 | $17.5M | 72 | 0% | N/A | N/A |
#3 | $17.5M | 72 | 0% | N/A | N/A |
#4 | $15.3M | 63 | 7% | N/A | N/A |
#5 | $8.9M | 41 | 0% | N/A | N/A |
#6 | $15.8M | 65 | 0% | N/A | N/A |
#7 | $12.4M | 51 | 19% | N/A | N/A |
#8 | $5.1M | 27 | -4% | N/A | N/A |
#9 | $12.9M | 53 | 8% | N/A | N/A |
#10 | $6.7M | 31 | 7% | N/A | N/A |
What Is Aquavit?
Restaurants
keywords:N/AN/A
Total Funding
86
Number of Employees
$23.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aquavit News
2022-04-19 - Welsh cocktail pros compete to create welsh aquavit ...
Hot on the heels of launching Wales' first Aquavit, Monmouthshire-based Silver Circle Distillery recently invited a host of aspiring and...
2022-04-17 - Meet Dermatox, the Latest Neurotoxin Injectable Up for FDA Approval
With Aquavit's submission for approval by the FDA, the injectable joins a new wave of neurotoxins being introduced into the fast-growing non-...
2022-03-22 - Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
NEW YORK, March 24, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. announced today that it has submitted its IND package (Investigation...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.5M | 86 | -1% | N/A |
#2 | $23.2M | 86 | 62% | N/A |
#3 | $21.8M | 86 | 0% | N/A |
#4 | $21.5M | 86 | -9% | N/A |
#5 | $12.5M | 86 | 18% | N/A |